Alvogen Korea Co Ltd (002250)

Currency in KRW
27,900
0(0.00%)
Closed·
Showing Alvogen Korea historical data. For real-time data please try another search
Day's Range
27,90028,150
52 wk Range
028,150
Key Statistics
Bid/Ask
27,900.00 / 28,050.00
Prev. Close
28,100
Open
27,950
Day's Range
27,900-28,150
52 wk Range
0-0
Volume
-
Average Volume (3m)
1.99K
1-Year Change
-2.79%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Alvogen Korea Co Ltd Company Profile

Alvogen Korea Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. The company offers approximately 200 products. It provides anti-obesity treatment products, such as Furing and Oliet; products in various therapeutic categories, such as nephrology, cardiology, urology, oncology, neurology, endocrinology, and immunology; and incrementally modified and anti-virus drugs. The company offers its products through general hospitals and clinics in various dosage forms comprising tablets, coated tablets, capsules, granules, powders, and sachets. It is also involved in the research and development of fixed dose combination or controlled release, oncology, and CNS treatment drugs. The company was formerly known as Kunwha Pharmaceutical Co., Ltd. and changed its name to Alvogen Korea Co., Ltd. in June 2015. The company was founded in 1958 and is headquartered in Seoul, South Korea. Alvogen Korea Co., Ltd. operates as a subsidiary of Lotus Pharmaceutical Co., Ltd.

Employees
266

Earnings

Latest Release
Feb 29, 2020
EPS / Forecast
-- / --
Revenue / Forecast
46.41B / --
EPS Revisions
Last 90 days

002250 Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.